Sofosbuvir for the Treatment of COVID-19 Patients: Is It a Promising Therapeutic Medicine for the Inhibition of Severe Acute Respiratory Syndrome Coronavirus 2?
Letter to the Editor
Guardado en:
Autores principales: | Shahnaz Sali, Shiva Shabani, Soheil Tavakolpour |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hamadan University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/03a15f9329434da68a7648b87123c547 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Laboratory medicine resilience during coronavirus disease 2019 (COVID-19) pandemic
por: Lippi Giuseppe, et al.
Publicado: (2020) -
The Way of Severe Nursing of Respiratory System Failure
por: Qiongshan Liu, et al.
Publicado: (2021) -
Percutaneous Microwave Coagulation Therapy: A Promising Therapeutic Method for Breaking the Barrier of the Intertumor Heterogeneity
por: Haoyue Guo, et al.
Publicado: (2021) -
Emerging technologies in paediatric laboratory medicine
por: Mak Chloe, et al.
Publicado: (2021) -
A new journal for progress in Laboratory Medicine
por: Caballé Imma
Publicado: (2020)